Please wait while the transcript is being prepared...
0:00
Hello everyone,
I'm Allyson Pishko
from the University
of Pennsylvania,
and I'll be presenting
on anticoagulation
for venous thromboembolism.
0:10
The objectives for
today's talk will be to
review the indications
for anticoagulation,
then we will focus on a
specific indication for
anticoagulation -
venous thromboembolism.
We'll describe the phases of
treatment of venous thromboembolism,
then go on to describe
the mechanisms of
different anticoagulants.
We will then develop a framework
for determining the duration
of anticoagulation for
the treatment of venous
thromboembolism.
0:39
Anticoagulants are
popular medications as
there are many indications
for anticoagulation.
This includes prevention
or primary prophylaxis,
which is stroke prevention
and patients at high risk
due to atrial fibrillation.
It can be used for deep
vein thrombosis prophylaxis
in high-risk patients such as
hospitalized patients or
patients undergoing surgery.
It is also a medication that
is used in the treatment of
acute DVT or pulmonary embolism,
and also used in peripheral
arterial disease.
Anticoagulants can
also be used for
secondary prophylaxis, such as
the prevention of recurrent VTE
or recurrent stroke.
This talk will focus on
acute DVT or
pulmonary embolism treatment
with anticoagulants.
1:28
This is an important problem
as venous thromboembolism,
which includes pulmonary
embolism and DVT,
occurs commonly in
the population.
There are over 10
million cases of
VTE diagnosed
annually worldwide.
